Search results for "Endoscopic surveillance"

showing 2 items of 2 documents

The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg?

2013

Esophageal adenocarcinoma originates from columnar metaplastic epithelium of the distal esophagus. Various steps for this carcinogenetic process are known. Before the onset of high-grade dysplasia and adenocarcinoma, endoscopic surveillance is possible. However, because of the high cost of long-term surveillance, predictive factors for cancer are being evaluated to identify subjects with metaplasia who have a higher risk of developing malignancy. Molecular changes seem suitable for this purpose, but could require a high resource expenditure. While trying to identify the best predictive factors for cancer risk, molecular changes and differences in miRNA expression profile between the various…

DysplasiaPathologymedicine.medical_specialtyEsophageal NeoplasmsSettore MED/06 - Oncologia MedicaCarcinogenesisSettore MED/08 - Anatomia PatologicaAdenocarcinomaMalignancymedicine.disease_causeBarrett EsophagusMetaplasiamicroRNAmedicineHumansMetaplasiabusiness.industryEndoscopic surveillanceCancerBarrett's esophaguBarrett's esophagus; Metaplasia; Dysplasia; Adenocarcinoma; Endoscopic surveillance; miRNAsHematologymedicine.diseaseSettore MED/18 - Chirurgia GeneraleMicroRNAsOncologyDysplasiaBarrett's esophagusmiRNAsCancer researchDisease ProgressionAdenocarcinomamedicine.symptombusinessCarcinogenesisBiomarkersCritical reviews in oncology/hematology
researchProduct

Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement

2021

An expert consensus panel convened by the Italian Association for Inherited and Familial Gastrointestinal Tumors (Associazione Italiana per lo Studio della Familiarita ed Ereditarieta dei Tumori Gastrointestinali, AIFEG) reviewed the literature and agreed on a number of position statements regarding the definition and management of polyposis coli without an identified pathogenic mutation on the APC or MUTYH genes, defined in the document as NAMP (non-APC/MUTYH polyposis).

Oncologymedicine.medical_specialtyGastrointestinal tumorsColorectal cancerSurgical ManagementColorectal polyposisGermline03 medical and health sciencesCancer Genetic0302 clinical medicineMUTYHInternal medicinemedicineCancer GeneticsPolyposis coliHepatologyPathogenic mutationbusiness.industryColorectal polyposis not associated with APC/MUTYH mutationPolyposis management guidelineGastroenterologyExpert consensusEndoscopic surveillancemedicine.diseaseColorectal cancerConsensus development conference030220 oncology & carcinogenesisCancer Genetics; Colorectal cancer; Colorectal polyposis not associated with APC/MUTYH mutation; Consensus development conference; Endoscopic surveillance; Polyposis management guideline; Surgical Management030211 gastroenterology & hepatologybusiness
researchProduct